Interferon alpha inhibits antigen-specific production of proinflammatory cytokines and enhances antigen-specific transforming growth factor beta production in antigen-induced arthritis

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Chalise, Jaya P ^a   Narendra, Sudeep C ^a   Paudyal, Bhesh R ^a   Magnusson, Mattias ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CYTOKINE; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINANT ALPHA INTERFERON; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; ALPHA INTERFERON; AUTACOID; IMMUNOGLOBULIN G; METHYLATED ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HELPER CELL; HUMORAL IMMUNITY; LYMPH NODE CELL; MACROPHAGE; MOUSE; NONHUMAN; SPLEEN CELL; 129 MOUSE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CATTLE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL ARTHRITIS; FLOW CYTOMETRY; IMMUNOLOGY; INTRAARTICULAR DRUG ADMINISTRATION; KNOCKOUT MOUSE; METABOLISM; TIME;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; INJECTIONS, INTRA-ARTICULAR; INTERFERON-ALPHA; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, KNOCKOUT; SERUM ALBUMIN, BOVINE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884887490     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4326     Document Type: Article

References (46)

1. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006, 25:383-392. 10.1016/j.immuni.2006.08.010, 16979570.
2. Stubgen JP. Recombinant interferon-beta therapy and neuromuscular disorders. J Neuroimmunol 2009, 212:132-141. 10.1016/j.jneuroim.2009.04.015, 19443048.
3. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005, 115:1100.
4. Magnusson M, Zare F, Tarkowski A. Requirement of type I interferon signaling for arthritis triggered by double-stranded RNA. Arthritis Rheum 2006, 54:148-157. 10.1002/art.21517, 16385510.
5. Ying F, Chalise JP, Narendra SC, Magnusson M. Type I IFN protects against antigen-induced arthritis. Eur J Immunol 2011, 41:1687-1695. 10.1002/eji.201040956, 21469099.
6. Merrill JT, Wallace DJ, Petri M, Kirou KA, Yao Y, White WI, Robbie G, Levin R, Berney SM, Chindalore V, Olsen N, Richman L, Le C, Jallal B, White B. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon alpha monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Ann Rheum Dis 2011, 70:1905-1913. 10.1136/ard.2010.144485, 21798883.
7. Oliver BJ, Kohli E, Kasper LH. Interferon therapy in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of the comparative trials. J Neurol Sci 2011, 302:96-105. 10.1016/j.jns.2010.11.003, 21167504.
8. Zare F, Bokarewa M, Nenonen N, Bergstrom T, Alexopoulou L, Flavell RA, Tarkowski A. Arthritogenic properties of double-stranded (viral) RNA. J Immunol 2004, 172:5656-5663.
9. Kagari T, Doi H, Shimozato T. The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol 2002, 169:1459-1466.
10. Yarilina A, DiCarlo E, Ivashkiv LB. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol 2007, 178:2204-2211.
11. Corr M, Boyle DL, Ronacher L, Flores N, Firestein GS. Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta. Ann Rheum Dis 2009, 68:257-263. 10.1136/ard.2008.095356, 2713581, 18653628.
12. Ronnblom L, Alm GV, Eloranta ML. The type I interferon system in the development of lupus. Semin Immunol 2011, 23:113-121. 10.1016/j.smim.2011.01.009, 21292501.
13. Mangini AJ, Lafyatis R, Van Seventer JM. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1108:11-23. 10.1196/annals.1422.002, 17893966.
14. Kalliolias GD, Ivashkiv LB. Overview of the biology of type I interferons. Arthritis Res Ther 2010, 12(Suppl 1):S1. doi:10.1186/ar2881, 10.1186/ar2881, 2991774, 20392288.
15. Brackertz D, Mitchell GF, Vadas MA, Mackay IR. Studies on antigen-induced arthritis in mice, III. Cell and serum transfer experiments. J Immunol 1977, 118:1645-1648.
16. Martin E, Capini C, Duggan E, Lutzky VP, Stumbles P, Pettit AR, O'Sullivan B, Thomas R. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB. Arthritis Rheum 2007, 56:2255-2266. 10.1002/art.22655, 17599748.
17. Svard A, Kastbom A, Sommarin Y, Skogh T. Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis. Immunobiology 2013, 218(2):232-237. doi:10.1016/j.imbio.2012.04.011, 10.1016/j.imbio.2012.04.011, 22652412.
18. Ekerfelt C, Andersson M, Olausson A, Bergstrom S, Hultman P. Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice. Clin Exp Immunol 2007, 150:189-197. 10.1111/j.1365-2249.2007.03474.x, 2219278, 17672870.
19. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001, 14:461-470. 10.1016/S1074-7613(01)00126-1, 11336691.
20. Thompson JM, Whitmore AC, Staats HF, Johnston R. The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines. Vaccine 2008, 26:4998-5003. 10.1016/j.vaccine.2008.07.011, 3595171, 18656518.
21. Gonzalez-Quintela A, Alende MR, Lojo S, Perez LF, Padin E, Tome S, Vidal C. Total serum IgE levels in chronic hepatitis C: influence of interferon alpha therapy. Int Arch Allergy Immunol 2001, 125:176-181. 10.1159/000053812, 11435735.
22. Pene J, Rousset F, Brier F, Chretien I, Bonifay JY, Spits H, Yokota T, Arai N, Arai K, Banchereau J, et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natal Acad Sci USA 1988, 85:6880-6884.
23. Brennan FM, McInnis IB. Evidence that cytokines plays a role in rheumatoid arthritis. J Clin Invest 2008, 118:3537-3545. 10.1172/JCI36389, 2575731, 18982160.
24. Astray B, Herbert's E, Moodily KD. A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res 2011, 31:927-940. 10.1089/jir.2011.0094, 3234492, 22149412.
25. Take PP, Kaleen JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther 2011, 13:S5. 3123966, 21624184.
26. Henning son L, Eneljung T, Jirholt P, Tengvall S, Lidberg U, van den Berg WB, van de Loo FA, Gjertsson I. Disease-dependent local IL-10 production ameliorates collagen induced arthritis in mice. PloS One 2012, 7:e49731. 10.1371/journal.pone.0049731, 3500327, 23166758.
27. Jung S, Park YK, Lee H, Shin JH, Lee GR, Park SH. TGF-beta-treated antigen presenting cells suppress collagen-induced arthritis through the promotion of Th2 responses. Exp Mol Med 2010, 42:187-194. 10.3858/emm.2010.42.3.019, 2845003, 20164680.
28. Woods JM, Amin MA, Katschke KJ, Volin MV, Ruth JH, Connors MA, Woodruff DC, Kurata H, Arai KI, Haines GK, et al. Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum Gene Ther 2002, 13:381-393. 10.1089/10430340252792512, 11860705.
29. van den Berg WB, Joosten LA, van Lent PL. Murine antigen-induced arthritis. Methods Mol Med 2007, 136:243-253. 10.1007/978-1-59745-402-5_18, 17983153.
30. Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nature Rev Immunol 2004, 4:648-655.
31. Asselin-Paturel C, Brizard G, Pin JJ, Briere F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003, 171:6466-6477.
32. Notley CA, Brown MA, Wright GP, Ehrenstein MR. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol 2011, 186:4967-4972. 10.4049/jimmunol.1003021, 21383247.
33. Wong PK, Quinn JM, Sims NA, van Nieuwenhuijze A, Campbell IK, Wicks IP. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum 2006, 54:158-168. 10.1002/art.21537, 16385511.
34. Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2012, 51:v3-v11. 10.1093/rheumatology/kes113, 22718924.
35. de Paus RA, van Wengen A, Schmidt I, Visser M, Verdegaal EM, van Dissel JT, van de Vosse E. Inhibition of the type I immune responses of human monocytes by IFN-alpha and IFN-beta. Cytokine 2013, 61:645-655. 10.1016/j.cyto.2012.12.005, 23299081.
36. Riley CH, Jensen MK, Brimnes MK, Hasselbalch HC, Bjerrum OW, Straten PT, Svane IM. Increase in circulating CD4(+)CD25(+)Foxp3(+) T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-alpha. Blood 2011, 118:2170-2173. 10.1182/blood-2011-03-340992, 21708889.
37. Dikopoulos N, Bertoletti A, Kroger A, Hauser H, Schirmbeck R, Reimann J. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J Immunol 2005, 174:99-109.
38. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, Munn DH, Mellor AL. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 2009, 183:2475-2483. 10.4049/jimmunol.0900986, 3677163, 19635913.
39. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886. 10.1084/jem.20030152, 2194145, 14676299.
40. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 2010, 40:1830-1835. 10.1002/eji.201040391, 20583029.
41. Xu L, Wang C, Zhou Y, Ren T, Wen Z. CpG oligonucleotides induce the differentiation of CD4(+)Th17 cells by triggering plasmacytoid dendritic cells in adoptively cell transfer immunotherapy. Immunol Lett 2012, 142:55-63. 10.1016/j.imlet.2011.12.006, 22249078.
42. Ou-Yang HF, Hu XB, Ti XY, Shi JR, Li SJ, Qi HW, Wu CG. Suppression of allergic airway inflammation in a mouse model by Der p2 recombined BCG. Immunology 2009, 128:e343-e352. 10.1111/j.1365-2567.2008.02970.x, 2753957, 19191902.
43. Gjertsson I, Laurie KL, Devitt J, Howe SJ, Thrasher AJ, Holmdahl R, Gustafsson K. Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis. Mol Ther 2009, 17:632-640. 10.1038/mt.2009.299, 2835107, 19174762.
44. Santos LM, Al-Sabbagh A, Londono A, Weiner HL. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Cell Immunol 1994, 157:439-447. 10.1006/cimm.1994.1240, 7520838.
45. Jittimanee J, Sermswan RW, Kaewraemruaen C, Barta JR, Macinnes JI, Maleewong W, Wongratanacheewin S. Protective immunization of hamsters against Opisthorchis viverrini infection is associated with the reduction of TGF-beta expression. Acta Tropica 2012, 122:189-195. 10.1016/j.actatropica.2012.01.010, 22266215.
46. Kochetkova I, Thornburg T, Callis G, Pascual DW. Segregated regulatory CD39+CD4+ T cell function: TGF-beta-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis. J Immunol 2011, 187:4654-4666. 10.4049/jimmunol.1100530, 3237119, 21967895.